Of these inhibitors, common STAT inhibitors used to treat leukemia include Niclosamide, fludarabine, OPB-51,602, BBI-608, OPB-111,077, C188-9, SD-36, AZD9150, CpG-STAT3-siRNA, CpG-STAT3dODN, AC-4-130, BP-1-108, and BP-1-107. This evidence concerns the gene STAT3 and leukemia.